Literature DB >> 30058911

Healthy obesity as an intermediate state of risk: a critical review.

J A Bell1,2, M Hamer2.   

Abstract

INTRODUCTION: Obesity is a top public health priority but interventions to reverse the condition have had limited success. About one-in-three obese adults are free of metabolic risk factor clustering and are considered 'healthy', and much attention has focused on the implications of this state for obesity management. Areas covered: We searched for individual studies, systematic reviews, and meta-analyses which examined correlates and outcomes of metabolically healthy obesity. We discuss the key roles of fat distribution and physical activity in determining healthy vs. unhealthy obesity and report a greatly increased risk of incident type 2 diabetes associated with healthy obesity vs. healthy normal weight, among other outcomes. We argue that despite inconsistencies in the definition, patterns across studies clearly show that healthy obesity is a state of intermediate disease risk. Expert commentary: Given the current state of population-level evidence, we conclude that obesity and metabolic dysfunction are inseparable and that healthy obesity is best viewed only as a state of relative health but not of absolute health. We recommend that weight loss through energy restriction be a stand-alone target in addition to increased physical activity for minimising risk of future disease.

Entities:  

Keywords:  Obesity; body mass index; cardiorespiratory fitness; cardiovascular disease; epidemiology; metabolic health; mortality; physical activity; review; type 2 diabetes

Year:  2016        PMID: 30058911     DOI: 10.1080/17446651.2016.1220298

Source DB:  PubMed          Journal:  Expert Rev Endocrinol Metab        ISSN: 1744-6651


  1 in total

1.  Association of Metabolically Healthy and Unhealthy Obesity Phenotype with Markers Related to Obesity, Diabetes among Young, Healthy Adult Men. Analysis of MAGNETIC Study.

Authors:  Mateusz Lejawa; Kamila Osadnik; Zenon Czuba; Tadeusz Osadnik; Natalia Pawlas
Journal:  Life (Basel)       Date:  2021-12-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.